Simon Müller

2.0k citations

51 papers · 1.3k indexed · h-index 20

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 10%
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation
- RNA and protein synthesis mechanisms

Papers in ⓘ

Molecular Biology 25
- RNA Research and Splicing 14
- RNA modifications and cancer 12
- RNA and protein synthesis mechanisms 5
Oncology 15
- Drug Transport and Resistance Mechanisms 13

Co-authors: Stefan Hüttelmaier (15 shared papers)Nadine Bley (11 shared papers)Markus Glaß (10 shared papers)Marcell Lederer (9 shared papers)Tommy Fuchs (6 shared papers)Jacob Haase (3 shared papers)Bianca Busch (4 shared papers)Joachim Geyer (16 shared papers)
Journals: Nucleic Acids Research (5 papers)Scientific Reports (4 papers)Viruses (4 papers)Nature Communications (3 papers)Frontiers in Veterinary Science (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Simon Müller

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Simon Müller

Since Specialization

Citations

This map shows the geographic impact of Simon Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Müller more than expected).

Fields of papers citing papers by Simon Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Müller. The network helps show where Simon Müller may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Müller Line = papers co-authored together Simon Müller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner Nucleic Acids Research ·Simon Müller, Markus Glaß, Anurag Kumar Singh, Jacob Haase, Nadine Bley, Tommy Fuchs, Marcell Lederer, Andreas Dahl, Huilin Huang, Jianjun Chen, Guido Posern, Stefan Hüttelmaier	2018	290
2	The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer Nucleic Acids Research ·Simon Müller, Nadine Bley, Bianca Busch, Markus Glaß, Marcell Lederer, Claudia Misiak, Tommy Fuchs, Alice Wedler, Jacob Haase, Jean B. Bertoldo, Patrick Michl, Stefan Hüttelmaier	2020	108
3	IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors Nucleic Acids Research ·Simon Müller, Nadine Bley, Markus Glaß, Bianca Busch, Vanessa Rousseau, Danny Misiak, Tommy Fuchs, Marcell Lederer, Stefan Hüttelmaier	2018	103
4	The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family Nucleic Acids Research ·Bianca Busch, Nadine Bley, Simon Müller, Markus Glaß, Danny Misiak, Marcell Lederer, Martina Vetter, Hans‐Georg Strauß, Christoph Thomssen, Stefan Hüttelmaier	2016	91
5	Combinatorial recognition of clustered RNA elements by the multidomain RNA-binding protein IMP3 Nature Communications ·Tim Schneider, Lee-Hsueh Hung, Masood Aziz, Anna Wilmen, Stephanie Thaum, Jacqueline Wagner, Robert Janowski, Simon Müller, Silke Schreiner, Peter Friedhoff, Stefan Hüttelmaier, Dierk Niessing, Michael Sattler, Andreas Schlundt, Albrecht Bindereif	2019	64
6	Characterisation of the hepatitis B virus cross-species transmission pattern via Na+/taurocholate co-transporting polypeptides from 11 New World and Old World primate species PLoS ONE ·Simon Müller, Alexander König, Barbara Döring, Dieter Glebe, Joachim Geyer	2018	36
7	Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors The Pharmacogenomics Journal ·Arian Emami Riedmaier, Oliver Burk, Barbara A. C. van Eijck, Elke Schaeffeler, Kathrin Klein, Sarah Fehr, Saskia Biskup, Simon Müller, Stefan Winter, Ulrich M. Zanger, Matthias Schwab, Anne T. Nies	2015	34
8	Clinical Course and Long-Term Outcome of Hantavirus-Associated Nephropathia Epidemica, Germany Emerging infectious diseases ·Joerg Latus, Matthias Schwab, Evelina Tacconelli, F. Pieper, Daniel Wegener, Juergen Dippon, Simon Müller, David Zakim, Stephan Segerer, Daniel Kitterer, Martin Priwitzer, Barbara Mezger, Birgit Walter-Frank, A. Corea, Albrecht Wiedenmann, Stefan Brockmann, Christoph Pöhlmann, Mark Dominik Alscher, Niko Braun	2014	33
9	Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids Scientific Reports ·Michael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Müller, Nora Goldmann, Felix Lehmann, Sami Alakurtti, Jari Yli‐Kauhaluoma, Dieter Glebe, Joachim Geyer	2020	30
10	IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer Frontiers in Molecular Biosciences ·Markus Glaß, Danny Misiak, Nadine Bley, Simon Müller, Sven Hagemann, Bianca Busch, Alexander Rausch, Stefan Hüttelmaier	2021	30
11	IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer RNA Biology ·Nadine Bley, Annekatrin Schott, Simon Müller, Danny Misiak, Marcell Lederer, Tommy Fuchs, Chris Aßmann, Markus Glaß, Christian Ihling, Andrea Sinz, Nikolaos Pazaitis, Claudia Wickenhauser, Martina Vetter, Olga Ungurs, Hans‐Georg Strauß, Christoph Thomssen, Stefan Hüttelmaier	2020	29
12	Factors triggering an additional resection and determining residual tumor volume on intraoperative MRI: analysis from a prospective single-center registry of supratentorial gliomas Neurosurgical FOCUS ·Moritz Scherer, Christine Jungk, Alexander Younsi, Philipp Kickingereder, Simon Müller, Andreas Unterberg	2016	25
13	The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes BMC Cancer ·Maria Thomas, Christine Bayha, Kathrin Klein, Simon Müller, Thomas S. Weiß, Matthias Schwab, Ulrich M. Zanger	2015	24
14	Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice NAR Cancer ·Simon Müller, Alice Wedler, Judith Breuer, Markus Glaß, Nadine Bley, Marcell Lederer, Jacob Haase, Claudia Misiak, Tommy Fuchs, Alina Ottmann, Tessa Schmachtel, Lyudmila Shalamova, Alexander Ewe, Achim Aigner, Oliver Roßbach, Stefan Hüttelmaier	2020	24
15	RNA-binding proteins in cancer drug discovery Drug Discovery Today ·Jean B. Bertoldo, Simon Müller, Stefan Hüttelmaier	2023	22
16	IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection Viruses ·Massimo Palatini, Simon Müller, Michael Kirstgen, Silke Leiting, Felix Lehmann, Lena Soppa, Nora Goldmann, Christin Müller, Kira Alessandra Alicia Theresa Lowjaga, Jörg Alber, Giuliano Ciarimboli, John Ziebuhr, Dieter Glebe, Joachim Geyer	2022	22
17	Homo- and heterodimerization is a common feature of the solute carrier family SLC10 members Biological Chemistry ·Saskia Noppes, Simon Müller, Josefine Bennien, Matthias Holtemeyer, Massimo Palatini, Regina Leidolf, Jörg Alber, Joachim Geyer	2019	22
18	Musashi–1—A Stemness RBP for Cancer Therapy? Biology ·Nadine Bley, Ali Hmedat, Simon Müller, Robin Benedikt Rolnik, Alexander Rausch, Marcell Lederer, Stefan Hüttelmaier	2021	21
19	Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood Clinical Chemistry and Laboratory Medicine (CCLM) ·Henar Valbuena, Maria Shipkova, Sophie-Maria Kliesch, Simon Müller, Eberhard Wieland	2015	20
20	The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling Scientific Reports ·Emre Karakuş, Marie Wannowius, Simon Müller, Silke Leiting, Regina Leidolf, Saskia Noppes, Stefan Oswald, Martin Diener, Joachim Geyer	2020	19

About Simon Müller

Simon Müller is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Infectious Diseases, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Research and Splicing (14 papers), Drug Transport and Resistance Mechanisms (13 papers), RNA modifications and cancer (12 papers), Hepatitis B Virus Studies (9 papers), Cancer-related molecular mechanisms research (8 papers), RNA and protein synthesis mechanisms (5 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (544 citations), Molecular Biology (871 citations), Hepatology (66 citations), Oncology (213 citations) and Transplantation (14 citations). Simon Müller has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Stefan Hüttelmaier, Nadine Bley, Markus Glaß, Marcell Lederer, Tommy Fuchs, Jacob Haase, Bianca Busch, Joachim Geyer, Danny Misiak and Huilin Huang. Their work appears in journals such as Nucleic Acids Research, Scientific Reports, Viruses, Nature Communications and Frontiers in Veterinary Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact